Last updated: December 22, 2023
Sponsor: NYU Langone Health
Overall Status: Trial Not Available
Phase
N/A
Condition
Multiple Sclerosis
Memory Loss
Neurologic Disorders
Treatment
Computerized CT (Cognitive Training)
TRPMS (Transcranial Rotating Permanent Magnet Stimulation)
Aerobic Exercise Program
Clinical Study ID
NCT04578041
20-01101
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: In order to be eligible to participate in Arm 1 of this study, an individual must meet allof the following criteria:
- Between ages 18 - 70
- SDMT z-score ≥ -3.0
- Wide Range Achievement Test-4th Edition (WRAT-4) Reading Recognition scaled score ≥ 85
- Definite MS diagnosis as assessed by a licensed physician (all subtypes - RRMS, PPMS,SPMS)
- Expanded Disability Status Scale (EDSS) ≤ 6.5
- Clinically stable disease course with absence of relapse within the past 30 days
- Able to understand the informed consent process and provide consent to participate inthe study
- Complete the TMS screening questionnaire
- Able to commit to study timeframe
- Clinically significant gate deviations (T25-FW > 5.0 seconds)
- Able to walk independently with or without assistive device (i.e. cane, crutches, orwalking frames) for medium distance
- Able to exercise with seated elliptical machine In order to be eligible to participate in Arm 2 of this study, an individual must meet allof the following criteria:
- Between ages 18 - 70
- SDMT z-score ≥ -3.0
- Wide Range Achievement Test-4th Edition (WRAT-4) Reading Recognition scaled score ≥ 85
- Definite MS diagnosis as assessed by a licensed physician (all subtypes - RRMS, PPMS,SPMS)
- Expanded Disability Status Scale (EDSS) ≤ 6.5
- Clinically stable disease course with absence of relapse within the past 30 days
- Able to understand the informed consent process and provide consent to participate inthe study
- Complete the TMS screening questionnaire
- Able to commit to study timeframe
- Elevated symptoms of depression as determined by BDI of ≥ 4
Exclusion
Exclusion Criteria:
- Visual, auditory or motor deficits that would influence participant safety as assessedby a licensed physician
- History of seizure or epileptic history as assessed by licensed physician
- Medication which significantly lower the seizure threshold as assessed by licensedphysician
- Primary psychiatric disorder that would influence ability to participate
- Uncontrolled headaches and migraine or recent changes in the rate or severity of headpressure, headache, or migraine in the past two weeks
- History of stroke or head trauma (e.g., head injury, brain surgery) or medical deviceimplanted in the head (e.g. Deep Brain Stimulator) or in the neck (e.g. Vagus NerveStimulator)
- History of uncontrolled or labile hypertension
- Other serious uncontrolled medical condition or recent medical traumas
- Presence of metal or electronic implants in the body contraindicated for TMS
- Alcohol or other substance use disorder
- Pregnant or breastfeeding
- History of clinically significant abnormalities on electrocardiogram (EKG) (Arm 1only)
- Presence of chronic medical illness and/or severe ataxia (Arm 1 only)
- Functional surgery for lower limb in the past 6 months (e.g. hip or knee replacement) (Arm 1 only)
- Lower limb Botulinum toxin injection within the past 2 months (Arm 1 only)
Study Design
Treatment Group(s): 3
Primary Treatment: Computerized CT (Cognitive Training)
Phase:
Study Start date:
January 01, 2023
Estimated Completion Date:
March 05, 2023